How to evaluate the cost impact of using disposables in biomanufacturing

BioPharm International

Volumn 21, Issue 6, 2008, Pages 26-30

  Sinclair, Andrew ^a  

^a BioPharm Services UK   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CAPITAL; CHROMATOGRAPHY; COST BENEFIT ANALYSIS; DISPOSABLE EQUIPMENT; DRUG MANUFACTURE; METHODOLOGY; SHORT SURVEY; TECHNOLOGY;

EID: 47249109011     PISSN: 1542166X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (5)

1. Sinclair A, Monge M. Biomanufacturing for the 21st century: Designing a concept facility based on single-use systems. Bioprocess Int. 2004 Oct supp;26-31.
2. Lim J, Sinclair A, Kim D, Gottschalk U. Economic benefits of single-use membrane chromatography in polishing: a cost of goods model. Bioprocess Int. 2007 Feb; 5(2):48-56.
3. Van Reiss R. Genentech. IBC IBC Bioeconomics Conference; 1999; Washington, DC.
4. Lim J, Sinclair A. Process economy of disposable manufacturing. Process models to minimize upfront investment. Amer Pharm Rev. 2007 Sept/Oct;10(6):114- 21.
5. Sinclair A, Monge M. Concept facility based on single-use systems, part 2. Leading the way for biomanufacturing in the 21st century. BioProcess Int. 2005 Oct supp;51-55.